These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 396527)

  • 21. [Supplementary drug therapy in the treatment of venous insufficiency. Results of a double-blind study].
    Coninx S
    Fortschr Med; 1974 Jun; 92(18):792-4. PubMed ID: 4605974
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
    Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
    Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
    Bopp J
    Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
    [No Abstract]   [Full Text] [Related]  

  • 24. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
    Cesarone MR; Belcaro G; Grossi MG
    Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
    [No Abstract]   [Full Text] [Related]  

  • 25. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and Daflon.
    Frick RW
    Angiology; 2000 Mar; 51(3):197-205. PubMed ID: 10744007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, cross-over trial of O-(beta-hydroxyethyl) rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
    Faga A
    Br J Plast Surg; 1988 Jul; 41(4):444-5. PubMed ID: 3395777
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
    Pedersen FM; Hamberg O; Sørensen MD; Neland K
    Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.
    Poynard T; Valterio C
    Vasa; 1994; 23(3):244-50. PubMed ID: 7975870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Venoruton in chronic venous insufficiency].
    Golden GJ
    Ugeskr Laeger; 1993 Jan; 155(3):182-3. PubMed ID: 8421882
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug treatment of chronic venous insufficiency and venous ulceration: a review.
    Cheatle TR; Scurr JH; Smith PD
    J R Soc Med; 1991 Jun; 84(6):354-8. PubMed ID: 2061904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Main principles in the treatment of patients with chronic venous insufficiency of the lower extremities with trophic lesions].
    Kosenkov AN; Mizaushev BA; Tsarenko IA; Aslanov AD; Siniavin GV; Zhirikov AV
    Khirurgiia (Mosk); 2005; (6):68-72. PubMed ID: 16050045
    [No Abstract]   [Full Text] [Related]  

  • 32. [Venoryton in the treatment of crural varicose veins].
    Nowak A; Kadyków M; Ksiazek M
    Przegl Dermatol; 1980; 67(4):481-6. PubMed ID: 7433713
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.
    Perrin M; Ramelet AA
    Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):117-25. PubMed ID: 21126890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activity testing of clobenoside gel in the treatment of chronic venous insufficiency].
    Lindemayr H; Santler R; Thalmann R; Limoni C
    Schweiz Rundsch Med Prax; 1988 Feb; 77(8):182-4. PubMed ID: 3358049
    [No Abstract]   [Full Text] [Related]  

  • 36. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
    Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y
    Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Venacorn in the treatment of varicose leg ulcer].
    Jacyk W; Wilczek-Stepniak J
    Przegl Lek; 1973; 30(5):476-8. PubMed ID: 4198775
    [No Abstract]   [Full Text] [Related]  

  • 40. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
    Becker HM; Niedermaier G; Orend KH
    Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.